ABSTRACT Virus capsid assembly has attracted considerable interest from the biophysical modeling community as a model system for complicated self-assembly processes. Simulation methods have proven valuable for characterizing the space of possible kinetics and mechanisms of capsid assembly, but they have so far been able to say little about the assembly kinetics or pathways of any specific virus. It is not possible to directly measure the detailed interaction rates needed to parameterize a model, and there is only a limited amount of experimental evidence available to constrain possible pathways, with almost all of it gathered from in vitro studies of purified coat proteins. In prior work, we developed methods to address this problem by using simulation-based data-fitting to learn rate parameters consistent with both structure-based rule sets and experimental light-scattering data on bulk assembly progress in vitro. We have since improved these methods and extended them to fit simulation parameters to one or more experimental light-scattering curves. Here, we apply the improved data-fitting approach to three capsid systems-human papillomavirus (HPV), hepatitis B virus (HBV), and cowpea chlorotic mottle virus (CCMV)-to assess both the range of pathway types the methods can learn and the diversity of assembly strategies in use between these viruses. The resulting fits suggest three different in vitro assembly mechanisms for the three systems, with HPV capsids fitting a model of assembly via a nonnucleation-limited pathway of accumulation of individual capsomers while HBV and CCMV capsids fit similar but subtly different models of nucleation-limited assembly through ensembles of pathways involving trimerof-dimer intermediates. The results demonstrate the ability of such data fitting to learn very different pathway types and show some of the versatility of pathways that may exist across real viruses.
INTRODUCTION
Simulation methods have long played an important role in understanding the biophysics of molecular assembly systems (1, 2) , especially where direct experimental observation is infeasible. Virus capsid assembly has proven a particularly fertile field for theoretical and computational models. For example, simulation methods have made it possible to infer various emergent properties of hypothetical assembly models (3) (4) (5) (6) , to explore the effects of perturbations in parameter spaces (5, (7) (8) (9) , and to examine possible assembly pathways and mechanisms accessible to theoretical models (7, (10) (11) (12) (13) . Simulations have so far had limited value for predicting the assembly mechanisms of specific viruses, though, primarily because they depend on physical parameters that cannot be directly measured by any contemporary technology. Those parameters in capsid assembly models would typically refer to association and dissociation rates (also called on-and off-rates) among coat proteins.
Several attempts have been made to bridge this gap, such as using simulation models to find rate ranges plausible for productive assembly (14, 15) , using analytical fits of small numbers of parameters to match to light-scattering data (16), applying additional constraints on possible assembly pathways such as those imposed by virus-specific nucleic acid interactions (17) , inferring approximate averaged rates from global estimates of the free energy of assembly (16) , inferring approximate rate parameters from structural models (18, 19) , or scanning parameter spaces to put constraints on the range of possible behaviors of a viral system (5, 6, 8, 9, 13, 20, 21) . Precise rate constants are not known for any real viral system, however, and previous simulation studies have suggested that the assembly mechanisms can be highly sensitive to changes in these and other parameters (13) , casting doubt on the ability of any such approximations to yield faithful reproductions of real assembly behavior.
In prior work, we proposed a strategy of using optimization algorithms to fit generic coarse-grained simulation models to specific virus capsid systems (22) . Parameter estimation in a computational or mathematical model is typically treated as an optimization problem over the parameter space to minimize deviation between the model and some measurable behavior of the real system. In the process, one infers parameters explaining the data that might be impossible to compute analytically from any feasible experimental measure. Our prior work used a previously developed model for stochastic simulation of viruses from coarse-grained geometric rule sets, seeking to minimize the deviation between indirect measures of assembly progress and projections of those measures implied by the simulations.
To deal with the particular challenges of capsid assembly systems, the method used a novel, to our knowledge, datafitting algorithm that interpolates between response surface (23) and quasigradient (24) approximations to provide fast convergence in smooth regions of the objective function while robustly handling bumpier regions. This method was specifically applied to light-scattering data, a widely used technology for monitoring in vitro capsid assembly systems (25) , although the algorithm is not specific to that data type. We demonstrated the approach on a single curve of human papillomavirus (HPV) light-scattering data from Casini et al. (26) , showing that the method could learn a set of physically plausible rate parameters to provide a good fit to the experimental data. This first study, however, left several important questions unanswered for evaluating the future prospects of these methods. Computationally speaking, it was unclear whether HPV was an unusual case in having a relatively simple objective surface and, if so, whether the strategy would generalize to systems with more complicated objective functions or multiple near-optimal solutions. Likewise, it was unclear if the model would have difficulty learning other sorts of assembly mechanisms than the simple capsomer accretion mechanism inferred for HPV. Similarly, while theoretical models suggest even simple structures can be efficiently produced by diverse sets of possible assembly pathways (13) , it was unclear how much of this potential diversity is found in actual viruses.
In this article, we seek to address these issues, improving algorithms for data-fitting to better handle the computational challenges of learning capsid assembly models and applying the improved methods to additional icosahedral capsid systems to assess both the variability in mechanisms between viruses and the ability of the data-fitting approach to learn such different mechanisms. To better distinguish between models of similar quality and thus reduce the potential for overfitting, we extended our algorithm to allow simultaneous fitting of curves from multiple assembly conditions. We also improved the ability of the approach to take advantage of parallel computing resources by replacing time-consuming large-scale simulations with many parallelized small-scale simulations. We have applied our improved methods to fitting light-scattering curves of hepatitis B virus (HBV) and cowpea chlorotic mottle virus (CCMV), as well as refitting the HPV system. The simulations suggest very different assembly mechanisms between the three viruses. In the process, they demonstrate the ability of the methods to learn diverse assembly mechanisms from these different models. In the process, this study also provides insight into possible mechanisms and pathways of capsid assembly and suggests some of the broader utility that simulation-based data-fitting may have for inferring otherwise hidden parameters of biophysical systems.
MATERIALS AND METHODS

Simulation model
Our parameter inference strategy relies on fitting coarse-grained simulations of virus capsid assembly to experimental measures of bulk assembly progress. We simulate the system using a stochastic simulator developed previously by our group for capsid assembly modeling (13) . The basic building block of our simulations is called a subunit, intended to be the basic assembly unit of the system. For viral systems, a subunit may be an individual coat protein or a small stable oligomer of coat proteins. For HPV, the subunit models a pentameric capsomer of coat proteins, due to strong experimental evidence that pentamers of coat protein are tightly associated in HPV and serve as the basic unit of capsid assembly (26, 27) . For hepatitis B virus (HBV) and cowpea chlorotic model virus (CCMV), we use coat dimer subunits because of similar evidence that tightly associated dimers are the basic assembly units of these systems (28) (29) (30) (31) .
Interactions between subunits are described by local rules (4, 5) , coarsegrained descriptions of the positions, affinities, and kinetics of subunitsubunit binding sites. A rule set will typically consist of multiple subunit rules describing the behaviors of distinct conformations of the assembly subunit(s). Fig. 1 shows rule sets for HPV, HBV, and CCMV described at the pentamer, dimer, and dimer resolutions, respectively. An HPV capsid will be described by interaction of 72 subunits following the rules in Fig. 1 A, an HBV capsid by 120 subunits following the rules of Fig. 1 C, and a CCMV capsid by 90 subunits following the rules in Fig. 1 E. Normally, a simulation will be initialized with a set of free subunits in sufficient numbers to build multiple capsids. Except where otherwise noted, each simulation trajectory was provided sufficient subunits to assemble 10 (HPV) or 5 (HBV and CCMV) complete capsids.
Simulations are implemented by DESSA, a stochastic simulator of capsid assembly that samples among possible assembly trajectories in accordance with the binding rates associated with the rule models (21) . DESSA uses a variant of the stochastic simulation algorithm (32) adapted for more efficient run time and memory usage on systems with large numbers of assembly intermediates (33) . This stochastic model was chosen because it allows kinetically correct sampling from the pathway set implied by a set of local rules in substantially shorter run times and with better scaling across parameter ranges than was possible with more realistic particlebased simulations (5) (6) (7) 9) . Details of the DESSA model are described in Zhang et al. (21) . Other simulation parameters are set as in our prior work (10, 13) .
Measuring quality of fit
The central task in our data fitting is to learn a set of rate parameters such that a simulated light-scattering dataset provides a close match to a set of true experimental curves. The output of the DESSA simulator is a time series providing numbers of oligomers of each size present as a function of time in the simulation. Following Casini et al. (26), we approximate the light-scattering curve produced by any given parameter set p over time t as follows:
Here R(t,p) is the value of a simulated light-scattering curve at time point t with parameter set p, n is the number of subunits in a full viral capsid, c is the concentration of subunits, N i (t,p) is the number of assemblies consisting of i subunits at time t for parameter set p, and k is a scaling factor. To simplify later formulas, we introduce the notation S(t,p) for the average Biophysical Journal 103 (7) 1545-1554 assembly size. The parameter set p consists of a set of on-and off-rates for all possible binding interactions described by the local rule set. R(t,p) is estimated for each parameter set p by averages over a set of trajectories to minimize stochastic noise, as described below. In contrast to our prior work (22) , we assume in general that we seek to fit p and possibly k to a set of true light-scattering curves E 1 , ., E m representing measurements of assembly at m distinct concentrations. We measure quality of fit of the corresponding simulated curves R 1 (t,p), ., R m (t,p) for a given parameter set p in terms of a root-mean-square deviation (RMSD),
where the deviation is computed over a series of discrete time points 0, ., t j , where t j is the total time measured in curve j.
The fitting also requires the scaling factor k, which we handled differently for the three viruses due to differences in how the data are reported in their studies. For HPV, the scaling factor is reported as k ¼ 7.04 Â 10 À8 (26) and that value is used throughout our study. No scaling factor is reported for the HBV and CCMV studies and we therefore treat these as additional unknowns to be learned. To infer k, we assume that no assembly has occurred at the initial time point following addition of assembly subunits for each true light-scattering curve, allowing us to use the approximation
We then seek a best-fit value k to match that constraint:
Here E* is the modified experimental curve that is shifted along the Y axis with E*(0) ¼ 0, so E*þk Â c starts at k Â c. By finding the zero of the derivative with respect to k, we derive a maximum likelihood estimate of
We vary the fitting strategy for the three viruses based on differences in how the data is reported. For HPV, we assume that there is a single known k and therefore we omit fitting of k. For HBV, we assume there is a single unknown k that is shared across all curves, and therefore learn this before multicurve fitting. For CCMV, the strategy differs in two respects:
1. We added a 2.5-s artificial lag phase for each curve to account for uncertainty in the timing of the beginning of assembly in each system, an important issue for CCMV because of its comparatively more rapid initiation than the other systems. 2. Due to normalization of the CCMV curves, we must fit each with a separate k and average the RMSD across curves:
Here, m is again the number of curves to be fit simultaneously, and k j is the scaling factor for the j th curve derived by applying Eqs. 3 and 4 to a single curve at a time.
Data-fitting algorithm
Data fitting was performed by an improved version of the optimization algorithm described in Kumar and Schwartz (22) . The approach is based on a search algorithm designed to locally optimize parameter sets by the quality-of-fit measure F, in turn used as the basis of a heuristic global search. The global search proceeds by an initial scan of a reduced parameter space derived by assuming all on-rates in the system are equal and all offrates are equal. We then perform a series of local searches, each using the local optimum of the previous search as an initial guess for a search in an expanded parameter space produced by allowing two previously equal offrates to vary independently. This process repeats until each off-rate is independently fit. We use a single on-rate for all binding sites but fit independent off-rates to balance the need for a model with enough degrees of freedom to fit the data against the need for a model simple enough to be computationally tractable. In our prior study of HPV alone (22), we instead used independent on-rates but chose the alternative here to implicitly model binding rate as diffusion-limited and thus essentially equal between binding sites. As we observe below, our believed-to-be-new method infers comparable HPV free energies and pathways to the prior study.
The order in which independent rates are introduced is determined manually for each virus. For HPV, after learning a single on-and off-rate for all binding sites, we then break the off-rates of the four sites into two groups (A j BCD), then three groups (A j BC j D), and finally four (A j B j C j D). For HBV, the steps by which groups are subdivided are AD j BC, A j D j BC, and A j D j B j C. The scheme for CCMV is AB j C, and A j B j C.
Local optimization is performed by estimating the quality of fit F at a series of nearby points on a grid in parameter space and using the points to infer a gradient vector used to predict a local optimum by steepest descent while also fitting a quadratic response surface with the nlinfit function in MATLAB (The MathWorks, Natick, MA) and predicting a local optimum of that response surface by the fmincon (MATLAB, The MathWorks) function. The method interpolates between these two approximations, automatically adjusting a weighting factor to favor the response surface prediction when the method improved the fit on the previous step and the steepest-descent prediction when the method failed to improve the fit on the previous step. This approach relies on a similar intuition to the standard Levenberg-Marquardt optimization method (34, 35) of interpolating between two forms of fit to empirically adjust between algorithms more suitable to smooth or rough regions of the search space. At each step, estimates are computed for this grid size by using the previous best guess, variations of plus or minus one grid step in each individual parameter, and variations of plus or minus the grid size in each pair of parameters. Due to space limitations, we refer the reader to the prior work (22) for a more detailed description of the fitting algorithm.
While stochastic simulations have algorithmic advantages for simulating large assembly systems (33) , they are problematic for data-fitting because of the noise they introduce into estimations of fit. There are two ways to compensate for this disadvantage: run larger individual simulations or run larger numbers of simulations and average the results. Our prior method relied primarily on the former strategy, but here we adopt the latter strategy
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to make better use of parallel computing resources to reduce computation time. We thus use relatively small numbers of subunits per simulation (720, 600, and 450 for HPV, HBV, and CCMV, respectively) but average many trajectories for each estimation of F. The numbers of simulations required were 120 trajectories per sampled point and 750 to evaluate a new local minimum. All the replica simulations needed at each step are automatically submitted and distributed to a compute cluster with 20 Xeon E5520 quad-core processors.
Data
Data for the three systems was gathered from prior studies by Casini et al. In each case, data consist of 90 light-scattering measurements of time progress of in vitro capsid assembly systems. For HPV, light-scattering data was gathered from purified L1 coat protein in citrate buffer with 0.5 M NaCl at pH 5.20 for 250 min per experiment (26) . For HBV, data was gathered from stock solutions of Cp149 coat dimers in 0.1 M sodium bicarbonate and 5 mM DTT at pH 9.5 for 600 s per experiment (16) . For CCMV, experiments were performed on solutions of coat dimers in 200 mM sodium citrate and 1 M NaCl, with data reported for 300 s per experiment (30) . For HPV, we fit to three curves corresponding to capsomer concentrations of 0.53 mM, 0.72 mM, and 0.80 mM. For HBV, we fit to coat dimer concentrations of 5.4 mM, 8.2 mM, and 10.8 mM. For CCMV, we fit to coat dimer concentrations of 14.1, 15.6, and 18.75 mM. In the case of HPV, we used data provided directly by David Wu (Department of Chemical and Biological Engineering, Colorado School of Mines) in electronic format, whereas for HBV and CCMV, we derived data from the appropriate figures in the references ( 
RESULTS AND DISCUSSION
Our algorithm begins in each case with an initial scan of a broad range within a simplified parameter space, in which all on-rates are assumed to be equal as are all off-rates. These initial scans are used to initialize the broader search, but are also useful for visualizing the complexity of the search space. Fig. 2 shows the results of these two-dimensional scans for the three viruses. Fig. 2 A reveals a comparatively simple objective function for HPV, consistent with the results of our prior work (22) , with a single strong local minimum and a relatively smooth approach to that minimum across the space examined. We note that this convex appearance does not guarantee that the space is truly convex, as there may be roughness at a finer scale than we examine, or that the full parameter space is similarly simple. Fig. 2 B shows a more complex objective function for HBV, with two comparably deep local minima and at least one other less-pronounced minimum. Fig. 2 C shows the comparable plot for CCMV, revealing a qualitatively similar multipeak profile to HBV, although with broader and more pronounced maxima and minima. Collectively, then, the three viruses show different portraits consistent with significant variability from system-to-system in the nature of the objective surface and the apparent difficulty of the associated global optimization problem.
We next proceeded with pseudo-global optimization of each capsid system starting from the point of lowest RMSD from each two-parameter scan. For HPV, the search began at association rate 1400 M À1 s À1 and dissociation rate 0.1 s
À1 . Local refinement in the two-parameter space adjusted those values to 1400 M À1 s À1 and 0.11 s À1 . We subsequently fixed the forward rate and locally searched in successively larger spaces of reverse rates, as described under Data-Fitting Algorithm, above. The algorithm led to improved fits by adjusting to nearly equal off-rates of À5 after successive expansions of the parameter space followed by local optimization. Moving from two to three parameters thus provided a comparable improvement to that achieved by the initial local optimization, but subsequent increases in parameter space provided little additional improvement. Table 1 shows the final fit parameters for HPV. Although we altered the basic model assumptions in this work relative to our prior work (22) by assuming a shared on-rather than off-rate, the search ended with comparable parameter estimates. As in that prior work, we found similar free energies between binding sites, with each now inferred to have a free energy of À5.5 to À5.6 kcal/mol. These energies are somewhat stronger than prior estimates of mean free energies of coat-coat binding in other systems, which have covered a range of~À2.8 kcal/mol for HBV (14) to À4.4 kcal/mol for phage P22 (15) . Nonetheless, estimates would appear to be physically plausible. The fit shows essentially equal affinity for all binding sites with the exception of a slightly stronger interaction for Aþ/AÀ binding, which binds pentameric capsomers to hexameric capsomers. Fig. 3 A shows the quality of fit of the best-fit model to the true light scattering from Casini et al. (26) , revealing a generally good fit to both short-and long-timescale features of the curves, although with a somewhat underestimated curve at 0.72 mM and a somewhat overestimated curve at 0.80 mM. In addition, the true data tends to show a sharper initial slope at the end of the lag phase than do the simulated curves, although that may in part reflect deviation between the idealized light-scattering model we assume and the true sensitivity of the instrument for smaller oligomers. A B C FIGURE 2 Contour plots demonstrating quality of fit in a reduced twodimensional parameter space. Each plot shows quality of fit as a function of one association rate along the x axis and one dissociation rate along the y axis, with all bonds assumed to exhibit the same pair of rates. Axes are shown on a logarithmic scale. (Quality of fit is denoted by shading of the curves, with lighter shades representing high RMSD, i.e., poor fit, and darker shades representing low RMSD, i.e., good fit.) (A) Quality of fit of HPV for unified dissociation rates from 0.001 to 10 s À1 and unified association rates from 14 to 1. 
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A key point of these studies is to infer features of capsid assembly pathways. For this purpose, we examined intermediate distributions as functions of time. Fig. 4 A plots the results from a sample trajectory for HPV at 0.80 mM. The curves show no preference for building up any specific pools of small oligomers. Neither do they show a pronounced depletion for larger oligomers, as we would expect for a nucleation-limited assembly. Rather, the plots show the mass fraction of each intermediate coming up slightly later and slightly lower than the next smaller intermediate. This pattern is consistent with a model of assembly by successive accretion of individual capsomers without a defined nucleation step. Fig. 5 , A-C, visualizes the pathway space by plotting how frequently any given reactant oligomer sizes are used to assemble any given product oligomer size. The plot confirms that each oligomer size is normally produced by addition of a single capsomer to the next smaller oligomer size, with the exception of some rare reactions between pairs of oligomers during the earlier steps of assembly. This conclusion is consistent with that found by our prior method fitting to a single light-scattering curve (22) .Comparison between concentrations shows that the same nonnucleation-limited capsomer addition pathway is used across the concentration range with only variation in the frequency of relatively rare oligomer-oligomer binding steps early in assembly. At higher concentrations, such oligomer-oligomer binding is more often observed, although still rare.
For HBV, we began the search at on-rate 1. Biophysical Journal 103 (7) 1545-1554 in a complete capsid, the average free energy per dimer in a complete capsid would be~À2.9 kcal/mol, well in line with earlier estimates by Ceres and Zlotnick (14) . The inferred model is thus also consistent with the argument of Zlotnick et al. for the necessity of weak interactions to allow efficient assembly. We note that the absolute rates inferred in this model are much higher than those inferred for HPV, suggesting that HBVassembly proceeds with far more trial-anderror, repeatedly attaching and detaching isolated proteins until stable substructures form and can act as ratchets forcing the assembly process forward. Fig. 3 B shows the corresponding curve fits of the best-fit parameters to the real light-scattering data. As with HPV, the model shows a generally good fit to both early and late phases of assembly, although with some underestimation of the 5.4-and 10.8-mM curves and overestimation of the 8.2-mM curve.
Profiles of intermediates and reaction usage present a very different picture for HBV than was seen for HPV. Fig. 4 B shows a sample simulation trajectory for the bestfit parameters at 10.8 mM. The most prominent feature of the plot is a set of intermittent spikes in which the system rapidly cycles through a series of successively larger intermediates, culminating in production of a new capsid. These spikes are the signature of nucleation-limited growth, with each spike touched off by production of some small nucleus followed by rapid completion of the capsid through a series of elongation reactions. Another prominent feature of the plot is the existence of a pool of free trimers (hexamers of coat protein) forming quickly and persisting during the assembly reaction. Monomers and trimers of subunits (dimers and hexamers of coat proteins) apparently reach an equilibrium with one another early in the reaction that readjusts with the production of each capsid.
The reaction usage profile in Fig. 5 B reveals that monomers and trimers are used at random for individual steps of the assembly, with monomers usually favored but trimers Biophysical Journal 103 (7) 1545-1554 used roughly 10-20% of the time at most elongation steps. The system thus appears to be described not by a single pathway but by an ensemble of many distinct assembly pathways. The production of small oligomers revealed in the inset shows a more complex profile, with more frequent use of trimers and occasionally pentamers, and with production of octamers in particular occurring primarily by binding trimers to pentamers. While it is difficult to define a precise set of steps as the nucleation from this profile, the results do suggest that a low-frequency pentameric form plays an important role in initiating assembly. The profiles are nearly identical across the twofold concentration change shown in Fig. 5, D- , whereas subsequent refinement allowed fitting to two distinct off-rates for the three binding interaction types: 3.0 Â 10 4 s À1 for types A and B and 3.9 Â 10 4 s À1 for type C. RMSD improved from 0.8846 after the grid search to 0.8529, 0.8142, and 0.8142 after local optimization in two-, three-, and four-dimensional spaces. The similarity in off-rates of type A and B is consistent with the similarity in structure and geometry of the two binding types. The final fits, provided in Table 1 , showed a free energy range from À2.0 kcal/mol to À2.2 kcal/mol, intermediate between the strong interactions inferred for HPV and the weaker interactions inferred for HBV. The free energies and the kinetic rates are closer to those of HBV and the model would thus seem to suggest that assembly of CCMV, like that of HBV, involves a considerable amount of trial-and-error before forming stable substructures by which the overall assembly can proceed.
The overall assembly process of the CCMV model also appears qualitatively more similar to that of HBV than HPV. Mass fractions of CCMV intermediates versus time, shown in Fig. 4 C for 14.1 mM, again show the spikes characteristic of a nucleation-limited growth mechanism. Like with HBV, there are also persistent pools of oligomers throughout the assembly, with trimers appearing to dominate as with HBV. Unlike with HBV, a small standing population of pentamers becomes apparent late in the reaction. Both viruses show a qualitatively similar process of gradual accumulation of trimers in the lag between nucleations, which are then rapidly depleted during elongation of a new capsid. Reaction frequencies visualized in Fig. 5 , G-I, shows that assembly most often proceeds by monomer additions, but that trimer additions occur with lower frequencies, providing an ensemble of secondary assembly pathways. Early steps in assembly show a similar frequency profile to that observed for HBV, although there also appears to be a single frequently used step involving large (10-mer and 17-mer) oligomers that is not seen with HBV. Like HBV, CCMV is inferred to assemble through an ensemble of distinct pathways rather than a single defined pathway. Pathway usage appears insensitive to at least the range of concentration changes examined in Fig. 5 , G-I.
CONCLUSION
In this work, we have advanced methods for simulationbased data fitting for learning physical parameters of selfassembly systems and applied these methods to a study of kinetic rate parameters of three icosahedral virus capsid assembly systems. The results of this work allow us to draw two conclusions about the methodology and the capsid systems themselves:
1. The results demonstrate that the algorithms are, at least in principle, able to learn different kinds of assembly pathways and rate parameters for a small collection of icosahedral viruses with qualitatively similar structures and bulk assembly kinetics. Our parameter estimation technique generates good fits between experimental and simulated light-scattering curves, even when fitting a common parameter set to multiple curves at different concentrations to reduce redundancy of solutions. 2. The results are suggestive of some of the variability in assembly mechanisms that may exist between structurally similar viruses. The inferred models show a variety of behaviors, including either nucleationlimited or nonnucleation-limited assembly, monomerbased or hierarchical oligomer-based assembly, and assembly consistent with a single well-defined pathway or assembly that can only be described as an ensemble of a very large collection of distinct pathways.
Two of the viruses, HBV and CCMV, fit pathways with many similar features despite different shell geometries shells and despite sizeable differences in inferred rate parameters. The third virus, HPV, shows very different behavior in both rates and pathways. These three examples, then, collectively demonstrate that there may not be any consistent paradigm of virus assembly but rather a diversity of strategies for assembly comparable to the great diversity seen in viral structures and other features of their life cycles. The inferred models raise several questions about assembly of the specific viruses examined. One surprising result is the apparent lack of nucleation-limited assembly in the HPV model, a feature noted in our earlier work on that system (22) . Numerous theoretical models have suggested nucleation-limited growth as a key feature for preventing kinetic traps in assembly (5, (7) (8) (9) 20 ) and indeed we see large amounts of incomplete species in the HPV simulations. This lack of nucleation-limited growth may reflect some inability of the model to learn the correct assembly pattern, perhaps because it lacks some important feature essential to true HPV assembly. The prior work left Biophysical Journal 103 (7) 1545-1554 open the possibility that the model-fitting technique might have some inherent inability to discover nucleation-limited parameter sets, although the currently available results from HBV and CCMV now refute that hypothesis.
Another intriguing observation is the apparent lack of a single defined pathway for HBV and CCMV in favor of what is, effectively, a random sampling from a large ensemble of possible pathways involving either incorporation of monomers or oligomers at each step of assembly. While there is no clear reason as to why virus assembly should not proceed by stochastic sampling from a large set of possible pathways, the assumption that a reaction has a defined pathway is nonetheless often implicit in how we reason about biochemical systems. A failure of this assumption may have important implications for our use of simplified theoretical models to describe and reason about such systems, especially on small scales at which the stochastic nature of the pathway space should be particularly pronounced.
Furthermore, an absence of any individual reactions necessary to productive assembly may have important practical implications for efforts to develop capsid assembly targeted antivirals (36) (37) (38) . A final observation is that the similar pathway usage across concentrations suggests that all three viruses sit at points in parameter space that are relatively insensitive to perturbation, in contrast to expectations from theoretical studies (13) that pathway usage is quite sensitive to small changes in model parameters across a large fraction of the parameter space. We can speculate that such robustness to perturbation might be a general feature evolutionarily selected in real capsid assembly, although far more examples would be needed to draw any such conclusion with confidence.
An obvious question with any such study is whether the parameters or pathways learned are in fact correct for the systems studied. While the results show good fits to the data and a reasonable ability to generalize to different concentrations for any single virus, they also show some imperfections, e.g., in the initial slope of the HPV curves at the end of the lag phase. Because we have no direct way to measure the true rates or to directly observe assembly pathways, we cannot be sure if these deviations reflect minor inaccuracies in the models or if they suggest the models are fundamentally wrong. It is also possible that there are spaces of distinct solutions equally consistent with the available data, in which case the method might arbitrarily fit to the wrong one.
Furthermore, this is a difficult optimization problem due to the high cost of simulations and the lack of any analytical guarantees of convexity of the search space, preventing an exhaustive global search of potential parameter sets. We therefore cannot guarantee that the solutions found are globally optimal, only that they provide reasonably good fits to the observed data. Even assuming the inferred models are correct, they are nonetheless correct models of in vitro assembly systems and not of the viruses in vivo.
It remains an open question whether the in vitro pathways are faithful reproductions of those used in vivo. There are many ways in which one might expect the environment of capsid assembly in vivo to differ from that of the in vitro assembly systems examined here, from generic features like nonspecific macromolecular crowding (39) to system-specific effects like the varying roles of scaffolding proteins and viral nucleic acid in capsid assembly (40) , or the importance of chaperone proteins in HPV assembly (41) .
There are many avenues by which this work might be further advanced. Our best-fit models allow us to make a variety of predictions about assembly intermediates and key steps in assembly that might, in principle, be experimentally tested in future studies. One might similarly ask how these models can assist us in designing strategies to selectively alter assembly pathways, for example by identifying vulnerable steps in assembly that could be targeted by antivirals (36) (37) (38) , or projecting how hypothetical mutations in coat proteins might alter assembly pathways. The computational models learned here also provide a platform from which one could test whether variations that are likely to separate in vitro from in vivo models would be expected to alter assembly pathways.
It would also be useful to examine a larger space of possible models to see how much greater diversity is found across the universe of real viruses and whether the common features of the systems observed here, such as their apparent robustness to parameter changes, are general features of real assembly systems. Such studies are infeasible at the time of this writing because there are few viruses for which in vitro models and light-scattering data are available, although the methods developed here, in principle, might be applied to other indirect measures of assembly progress. There is also considerable room for algorithmic improvements to accelerate the computationally costly searches, provide stronger guarantees of solution optimality, or find other bases by which one might distinguish solutions of similar quality of fit.
Finally, we note that virus capsids, due to their high symmetry and very large number of possible pathways, would be expected to be a particularly challenging system for such simulation-based data fitting. The ability of such methods to find good models for viral systems may therefore be taken as an indication that similar methods are likely to have much broader value in inferring experimentally inaccessible features of assembly systems or of biophysical systems in general.
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